Nations Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,082
| Closed | -$1.14M | – | 704 |
|
|
2024
Q3 | $1.14M | Buy |
1,082
+37
| +4% | +$38.9K | 0.08% | 254 |
|
|
2024
Q2 | $1.1M | Sell |
1,045
-21
| -2% | -$22.1K | 0.09% | 244 |
|
|
2024
Q1 | $1.03M | Buy |
1,066
+135
| +15% | +$130K | 0.09% | 257 |
|
|
2023
Q4 | $818K | Buy |
931
+6
| +0.6% | +$5.27K | 0.08% | 275 |
|
|
2023
Q3 | $761K | Buy |
925
+13
| +1% | +$10.7K | 0.08% | 274 |
|
|
2023
Q2 | $655K | Sell |
912
-2
| -0.2% | -$1.44K | 0.06% | 319 |
|
|
2023
Q1 | $751K | Buy |
914
+43
| +5% | +$35.3K | 0.08% | 274 |
|
|
2022
Q4 | $628K | Sell |
871
-21
| -2% | -$15.2K | 0.07% | 306 |
|
|
2022
Q3 | $614K | Sell |
892
-64
| -7% | -$44.1K | 0.09% | 246 |
|
|
2022
Q2 | $565K | Buy |
956
+1
| +0.1% | +$591 | 0.08% | 282 |
|
|
2022
Q1 | $667K | Buy |
955
+70
| +8% | +$48.9K | 0.08% | 269 |
|
|
2021
Q4 | $559K | Buy |
885
+25
| +3% | +$15.8K | 0.07% | 276 |
|
|
2021
Q3 | $521K | Sell |
860
-26
| -3% | -$15.8K | 0.08% | 259 |
|
|
2021
Q2 | $495K | Buy |
886
+32
| +4% | +$17.9K | 0.08% | 258 |
|
|
2021
Q1 | $404K | Sell |
854
-172
| -17% | -$81.4K | 0.09% | 248 |
|
|
2020
Q4 | $496K | Sell |
1,026
-12
| -1% | -$5.8K | 0.13% | 198 |
|
|
2020
Q3 | $581K | Buy |
1,038
+194
| +23% | +$109K | 0.18% | 151 |
|
|
2020
Q2 | $526K | Buy |
844
+130
| +18% | +$81K | 0.19% | 157 |
|
|
2020
Q1 | $349K | Buy |
+714
| New | +$349K | 0.15% | 171 |
|